ADMA Biologics Inc (ADMA) — Cash Flow-to-Debt Ratio
ADMA Biologics Inc (ADMA) has a Cash Flow-to-Debt Ratio of 0.11x as of June 2026, meaning its operating cash flow of $29.54 Million could theoretically repay 0% of its total liabilities ($276.00 Million) in one year. See financial agility of ADMA Biologics Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ADMA Biologics Inc Cash Flow-to-Debt Ratio (2006–2025)
Historical debt coverage capacity for ADMA Biologics Inc across 20 annual periods. For the full cash flow conversion analysis, see ADMA cash flow conversion.
Annual Cash Flow-to-Debt Ratio for ADMA Biologics Inc (2006–2025)
Year-by-year debt coverage analysis for ADMA Biologics Inc. Check ADMA Biologics Inc (ADMA) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | $50.40 Million | $146.92 Million | ▼ -59.6% |
| 2024 | 0.85x | $118.67 Million | $139.66 Million | ▲ +1773.0% |
| 2023 | 0.05x | $8.80 Million | $193.98 Million | ▲ +115.0% |
| 2022 | -0.30x | $-59.51 Million | $196.49 Million | ▲ +63.6% |
| 2021 | -0.83x | $-112.37 Million | $135.08 Million | ▲ +2.6% |
| 2020 | -0.85x | $-102.00 Million | $119.42 Million | ▼ -13.1% |
| 2019 | -0.76x | $-76.19 Million | $100.90 Million | ▲ +16.7% |
| 2018 | -0.91x | $-62.68 Million | $69.11 Million | ▼ -64.7% |
| 2017 | -0.55x | $-37.27 Million | $67.69 Million | ▲ +15.2% |
| 2016 | -0.65x | $-18.27 Million | $28.14 Million | ▲ +3.6% |
| 2015 | -0.67x | $-15.42 Million | $22.89 Million | ▲ +2.8% |
| 2014 | -0.69x | $-14.70 Million | $21.22 Million | ▲ +33.8% |
| 2013 | -1.05x | $-10.89 Million | $10.41 Million | ▲ +7.1% |
| 2012 | -1.13x | $-6.90 Million | $6.13 Million | ▲ +79.4% |
| 2011 | -5.47x | $-29.00K | $5.31K | ▼ -243.3% |
| 2010 | -1.59x | $-19.68K | $12.36K | ▲ +43.4% |
| 2009 | -2.82x | $-24.46 Million | $8.69 Million | ▲ +60.8% |
| 2008 | -7.18x | $-19.00 Million | $2.65 Million | ▼ -345.5% |
| 2007 | -1.61x | $-23.61 Million | $14.65 Million | ▲ +0.0% |
| 2006 | -1.61x | $-23.61 Million | $14.65 Million | — |